Bath & Body Works (NYSE:BBWI) Earns "Outperform" Rating from Telsey Advisory Group

Telsey Advisory Group restated their outperform rating on shares of Bath & Body Works (NYSE:BBWI - Free Report) in a report published on Thursday morning, MarketBeat Ratings reports. The firm currently has a $38.00 target price on the stock, down from their prior target price of $43.00.

A number of other equities analysts also recently commented on BBWI. The Goldman Sachs Group reduced their target price on shares of Bath & Body Works from $49.00 to $42.00 and set a "buy" rating for the company in a report on Tuesday, April 22nd. Cowen restated a "buy" rating on shares of Bath & Body Works in a research note on Thursday, February 27th. JPMorgan Chase & Co. lifted their price objective on shares of Bath & Body Works from $41.00 to $43.00 and gave the company an "overweight" rating in a research note on Monday, May 19th. Piper Sandler set a $39.00 target price on Bath & Body Works and gave the stock an "overweight" rating in a research note on Thursday, May 15th. Finally, Raymond James lowered their price target on shares of Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating on the stock in a report on Thursday, April 17th. Four research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $42.00.

Bath & Body Works Stock Performance

BBWI traded down $1.37 during trading on Thursday, hitting $26.75. 4,548,628 shares of the stock were exchanged, compared to its average volume of 4,999,498. Bath & Body Works has a 1 year low of $24.96 and a 1 year high of $52.99. The firm has a market cap of $5.70 billion, a price-to-earnings ratio of 6.53, a P/E/G ratio of 0.92 and a beta of 1.87. The firm has a 50 day simple moving average of $30.07 and a 200 day simple moving average of $33.97.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, May 29th. The company reported $0.49 EPS for the quarter, topping analysts' consensus estimates of $0.47 by $0.02. The company had revenue of $1.40 billion during the quarter, compared to the consensus estimate of $1.42 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. Bath & Body Works's revenue for the quarter was up 2.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.38 earnings per share. As a group, equities analysts anticipate that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, June 6th will be issued a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, June 6th. This represents a $0.80 annualized dividend and a yield of 2.99%. Bath & Body Works's dividend payout ratio is presently 21.33%.

Bath & Body Works declared that its board has initiated a stock repurchase program on Thursday, February 27th that permits the company to buyback $500.00 million in shares. This buyback authorization permits the company to reacquire up to 6.4% of its shares through open market purchases. Shares buyback programs are often a sign that the company's leadership believes its stock is undervalued.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of BBWI. SRS Capital Advisors Inc. boosted its stake in shares of Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock valued at $26,000 after acquiring an additional 329 shares during the last quarter. Northwest Bank & Trust Co lifted its holdings in Bath & Body Works by 2.9% in the 4th quarter. Northwest Bank & Trust Co now owns 14,700 shares of the company's stock valued at $533,000 after purchasing an additional 419 shares in the last quarter. Lindbrook Capital LLC boosted its stake in shares of Bath & Body Works by 81.9% during the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock worth $37,000 after purchasing an additional 431 shares during the last quarter. Cornerstone Investment Partners LLC boosted its stake in shares of Bath & Body Works by 3.8% during the 4th quarter. Cornerstone Investment Partners LLC now owns 12,248 shares of the company's stock worth $475,000 after purchasing an additional 452 shares during the last quarter. Finally, Nicolet Bankshares Inc. grew its holdings in shares of Bath & Body Works by 2.8% during the fourth quarter. Nicolet Bankshares Inc. now owns 17,232 shares of the company's stock worth $668,000 after buying an additional 463 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.